ACELYRIN INC. Made Big Gain
Mon, Jun 26, 2023 at 07:38 PM
ACELYRIN INC. (SLRN:NASDAQ) jumped higher at $23.9, a gain of 35.4%. On Mon, Jun 26, 2023, SLRN:NASDAQ touched a New 2-Week High of $23.9. The stock got featured on our News Catalysts scanner on Thu, Jun 15, 2023 at 07:38 PM in the 'EARNINGS' category. From Mon, Jun 12, 2023, the stock recorded 77.78% Up Days and 60.00% Green Days
About ACELYRIN INC. (SLRN:NASDAQ)
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
Top 10 Gainers:
- Trxade Group, Inc. (MEDS:NASDAQ), 93.84%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 81.36%
- MoonLake Immunotherapeutics Com (MLTX:NASDAQ), 77.55%
- Spark Networks SE (LOV:NASDAQ), 50.04%
- iMedia Brands, Inc. (IMBI:NASDAQ), 35.71%
- ACELYRIN INC. (SLRN:NASDAQ), 35.41%
- Shengfeng Development Limited (SFWL:NASDAQ), 33.2%
- Adagene Inc. (ADAG:NASDAQ), 30.37%
- Chemomab Therapeutics Ltd. (CMMB:NASDAQ), 28%
- Pharvaris N.V. (PHVS:NASDAQ), 27.76%